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INVITED COMMENTARY
Thomas W. Wakefield, MD, Ann Arbor, Mich
Endovenous treatment to obliterate the saphenous vein may
be performed by several techniques, including radiofrequency
ablation, laser treatment, or foam sclerotherapy. In this study, Dr
Merchant reports the data from an ongoing multicenter prospec-
tive registry of radiofrequency ablation treatment. Clinical and
duplex follow-up was performed within 1 week, at 6 months, at 1
year, and yearly thereafter. A total of 1006 patients and 1222 limbs
were treated; most involved the greater saphenous vein above the
knee. Vein occlusion rates ranged from 83.5% to 88.2%. Clinical
symptom improvement was noted in 70% to 80% of limbs with
anatomic failure and in 85% to 94% of limbs with anatomic success.
There is no question that endovenous saphenous vein ablation
is here to stay. The stage was set for such a procedure by the
determination that patients had better results with varicose vein
surgery if the saphenous vein was removed along with saphe-
nofemoral ligation, rather than with ligation alone.1 Saphenous
vein ablation, even in the presence of deep venous insufficiency,
can improve the manifestations of chronic venous insufficiency.2
As indicated by the authors, three randomized trials have estab-
lished the superiority of endovenous radiofrequency ablation to
saphenous vein surgery. The importance of the current study is to
show the durability of endovenous radiofrequency closure over 5
years. Two disappointing aspects of the report include the fact that
patient symptoms did not correlate with anatomic success or failure
and that body mass index correlated with anatomic failure. It is
exactly in this type of patient that endovenous ablation is most
appealing as opposed to operative ligation and stripping. Addition-
ally, before radiofrequency ablation is embraced as the best
method for saphenous vein ablation, more comparisons to laser
and foam sclerotherapy, techniques that have shown excellent
results, should be performed.3,4 Nonetheless, this study is an
important contribution to our understanding of the durability and
efficacy of this new modality for the treatment of saphenous vein
reflux.
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